NCT01396252View on ClinicalTrials.gov

Japanese Phase 1 Multiple Ascending Dose (MAD) Study

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Depression
Interventions
DRUG

BMS-820836

Tablets, Oral, 0.5 mg, Once daily, 14 days

DRUG

BMS-820836

Tablets, Oral, 1 mg, Once daily, 14 days

DRUG

BMS-820836

Tablets, Oral, 2 mg, Once daily, 14 days

DRUG

Placebo matching BMS-820836

Tablets, Oral, 0 mg, Once daily, 14 days

DRUG

BMS-820836

Tablets, Oral, (initiated at 1 mg and dose escalated to the target dose of 2 mg), Once daily, 14 days

Trial Locations (1)

1110052

Local Institution, Taito-Ku

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY